Steady growth and active M&As should continue
12/05/22 -"Bastide’s Q3 revenue continued to be affected by last year’s pandemic-led unfavourable comparable base but the anomalies should not persist for long. The group has maintained its FY guidance ..."
Pages
48
Language
English
Published on
12/05/22
You may also be interested by these reports :
14/09/26
Equity markets ended lower on the week ending September 11 as the renewed surge in energy prices revived inflation concerns and pushed bond yields ...
11/09/26
MedTech sector momentum has finally turned constructive in recent weeks, a welcome change after a multi-year stretch of post-covid destocking, supply ...
07/09/26
We have revised our estimates upwards and removed the 20% discount previously applied to the peer-based valuation. This optimism is supported by ...
04/09/26
Bastide ended FY25/26 above its revenue target, with Q4 organic growth recovering as the VPH headwind faded, confirming the one-off nature of the ...